Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1989;115(2):161-5.
doi: 10.1007/BF00397917.

Ester derivatives of the mammary-tumor-inhibiting antiestrogen 2,3-bis(2-fluoro-4-hydroxyphenyl)-2,3-dimethylbutane

Affiliations

Ester derivatives of the mammary-tumor-inhibiting antiestrogen 2,3-bis(2-fluoro-4-hydroxyphenyl)-2,3-dimethylbutane

W Schwarz et al. J Cancer Res Clin Oncol. 1989.

Abstract

The synthesis of the bisacetate (8), the bisdichloroacetate (9), the biscarbamate (10) and the bisphosphate (11) of the "partial" antiestrogen 2,3-bis(2-fluoro-4-hydroxyphenyl)-2,3-dimethylbutane (7) is described. In the case of 8-10 the introduction of ester functions slightly reduces the estrogen receptor affinity of 7. However, it was strongly diminished in 11. Compared with 7 the estrogenic potency of 8-11 is moderately increased. Compounds 8-11 cause a strong inhibition of the hormone-dependent MXT M3.2 mouse mammary tumor. Only 9 containing cytotoxic dichloroacetate groups shows a significantly better antitumor effect than 7.

PubMed Disclaimer

References

    1. Angerer E von (1984) Development of new drugs for endocrine tumor chemotherapy. Cancer Treat Rev 11 (suppl A):147–153 - PubMed
    1. Borgna JL, Rochefort H (1980) High affinity binding to the estrogen receptor of [3H]4-hydroxytamoxifen, an active antiestrogen metabolite. Mol Cell Endocrinol 20:71–85 - PubMed
    1. Chattaway FD, Saerens E (1920) n-Butyl chloroformiate and its derivatives. J Chem Soc 117:708–711
    1. Coezy E, Borgna JL, Rochefort H (1982) Tamoxifen and metabolites in MCF7 cells: correlation between binding to estrogen receptor and inhibition of cell growth. Cancer Res 42:317–323 - PubMed
    1. Druckrey H (1952) Experimentelle Grundlagen der Chemotherapie des Krebses. Dtsch Med Wochenschr 77:1534–1537 - PubMed

Publication types

MeSH terms

LinkOut - more resources